
Embla Medical's prosthetics device sales grew 7 percent in Q3 2026. The company's patient care segment grew zero.
Embla Medical posted $250 million in Q3 2026 sales, with its prosthetics and neuro orthotics segment growing at 7 percent organically. Its patient care segment, which covers owned O&P clinics, came in flat. That gap is worth understanding.
Read the full story














